Mercer Global Advisors Inc Novartis Ag Transaction History

Mercer Global Advisors Inc

  • $48.3 Billion
  • Q2 2025

A detailed history of Mercer Global Advisors Inc transactions in Novartis Ag stock. As of the latest transaction made, Mercer Global Advisors Inc holds 134,906 shares of NVS stock, worth $17.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
134,906
Previous 142,007 5.0%
Holding current value
$17.8 Million
Previous $15.8 Million 3.12%
% of portfolio
0.03%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$101.96 - $121.01 $724,017 - $859,292
-7,101 Reduced 5.0%
134,906 $16.3 Million
Q1 2025

May 15, 2025
SELL
$97.14 - $115.57 $364,469 - $433,618
-3,752 Reduced 2.57%
142,007 $15.8 Million
Q4 2024

Feb 14, 2025
SELL
$96.78 - $117.18 $233,336 - $282,520
-2,411 Reduced 1.63%
145,759 $14.2 Million
Q3 2024

Nov 13, 2024
SELL
$106.13 - $120.89 $518,445 - $590,547
-4,885 Reduced 3.19%
148,170 $17 Million
Q2 2024

Aug 12, 2024
BUY
$92.57 - $107.37 $489,232 - $567,450
5,285 Added 3.58%
153,055 $16.3 Million
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $3.5 Million - $3.98 Million
36,704 Added 33.05%
147,770 $14.3 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $263,061 - $289,490
2,851 Added 2.63%
111,066 $11.2 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $572,737 - $635,615
6,046 Added 5.92%
108,215 $11 Million
Q2 2023

Aug 14, 2023
BUY
$92.52 - $104.91 $939,170 - $1.06 Million
10,151 Added 11.03%
102,169 $10.3 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $340,767 - $395,184
-4,258 Reduced 4.42%
92,018 $8.47 Million
Q4 2022

Feb 08, 2023
SELL
$75.55 - $92.52 $39,814 - $48,758
-527 Reduced 0.54%
96,276 $8.73 Million
Q3 2022

Nov 15, 2022
BUY
$74.61 - $87.26 $167,051 - $195,375
2,239 Added 2.37%
96,803 $7.36 Million
Q2 2022

Aug 10, 2022
BUY
$80.52 - $93.75 $1.14 Million - $1.33 Million
14,190 Added 17.65%
94,564 $7.99 Million
Q1 2022

May 10, 2022
BUY
$80.11 - $90.62 $1.95 Million - $2.21 Million
24,334 Added 43.42%
80,374 $7.05 Million
Q4 2021

Feb 04, 2022
BUY
$79.7 - $88.13 $289,629 - $320,264
3,634 Added 6.93%
56,040 $4.9 Million
Q3 2021

Nov 10, 2021
BUY
$81.78 - $95.14 $914,545 - $1.06 Million
11,183 Added 27.13%
52,406 $4.29 Million
Q2 2021

Aug 10, 2021
SELL
$85.24 - $94.15 $372,498 - $411,435
-4,370 Reduced 9.58%
41,223 $3.76 Million
Q1 2021

Aug 10, 2021
BUY
$83.5 - $98.47 $60,537 - $71,390
725 Added 1.62%
45,593 $3.9 Million
Q1 2021

May 11, 2021
SELL
$83.5 - $98.47 $603,621 - $711,839
-7,229 Reduced 13.88%
44,868 $3.84 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $14,442 - $17,469
185 Added 0.36%
52,097 $4.92 Million
Q3 2020

Dec 10, 2020
SELL
$82.14 - $91.0 $2.61 Million - $2.89 Million
-31,722 Reduced 37.93%
51,912 $4.51 Million
Q2 2020

Aug 10, 2020
BUY
$80.93 - $91.1 $138,633 - $156,054
1,713 Added 2.09%
83,634 $7.31 Million
Q1 2020

May 18, 2020
BUY
$70.67 - $99.01 $1.05 Million - $1.48 Million
14,901 Added 22.23%
81,921 $6.75 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $107,293 - $121,310
1,272 Added 1.93%
67,020 $6.35 Million
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $363,117 - $400,133
4,245 Added 6.9%
65,748 $5.71 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $909,776 - $1.12 Million
12,066 Added 24.41%
61,503 $5.62 Million
Q1 2019

Apr 23, 2019
BUY
$75.32 - $86.15 $465,778 - $532,751
6,184 Added 14.3%
49,437 $4.75 Million
Q1 2019

Apr 12, 2019
BUY
$75.32 - $86.15 $3.26 Million - $3.73 Million
43,253 New
43,253 $3.71 Million

Others Institutions Holding NVS

# of Institutions
1,563
Shares Held
136M
Call Options Held
1.72M
Put Options Held
1.7M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email